Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Accenture
AstraZeneca
US Department of Justice
Dow
Julphar
Merck
Farmers Insurance

Generated: June 25, 2018

DrugPatentWatch Database Preview

NORTRIPTYLINE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Nortriptyline Hydrochloride patents expire, and when can generic versions of Nortriptyline Hydrochloride launch?

Nortriptyline Hydrochloride is a drug marketed by Ani Pharms Inc, Aurolife Pharma Llc, Mayne Pharma, Mylan, Taro Pharm, Teva, Pharm Assoc, and Taro. and is included in nine NDAs.

The generic ingredient in NORTRIPTYLINE HYDROCHLORIDE is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Drug patent expirations by year for NORTRIPTYLINE HYDROCHLORIDE
Pharmacology for NORTRIPTYLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for NORTRIPTYLINE HYDROCHLORIDE
Synonyms for NORTRIPTYLINE HYDROCHLORIDE
(2)10,d]cycloheptene-.delta.5.gamma.-propylamine, hydrochloride
00FN6IH15D
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methyl-, hydrochloride
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[ a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride
1-Propanamine,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride
10,11-Dihydro-5-(N-methyl-3-aminopropylidene)-5H-dibenzo[a,d]cycloheptene Hydrochloride
10,11-Dihydro-N-methyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5,gamma)-propylamine hydrochloride
3-(10,11-2H-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methyl-1-propanaminium chloride
3-(10,11-Dihydro-5H-dibenzo[a,d]-cyclohepten-5-ylidene)-N-methyl-1-propanamine
3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine Hydrochloride
3-(5,6-dihydrodibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-N-methylpropan-1-amine;hydrochloride
37025-22-2
5-(3-(Methylamino)propylidene)dibenzo(a,e)cyclohepta(1,5)diene hydrochloride
5-(3-Methylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene hydrochloride
5-[(3-(Methylamino)propylidene]-10,d]cycloheptene hydrochloride
5-[3-(Methylamino)propylidene]dibenzo[a,5]diene hydrochloride
5H-Dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine, 10-11-dihydro-N-methyl-, hydrochloride
5H-Dibenzo[a,.gamma.-propylamine, 10-11-dihydro-N-methyl-, hydrochloride
5H-Dibenzo[a,.gamma.-propylamine, 10,11-dihydro-N-methyl-, hydrochloride
72-69-5 (free base)
8057-32-7
894-71-3
AC1L9B17
AC1Q3BS4
Acetexa
AKOS015889095
Allegron
Altilev
AOB5370
API0003634
Ateben hydrochloride
Aventyl allegron
Aventyl hydrochloride
BG0274
C-46080
CAS-894-71-3
CCG-212718
CHEBI:7641
CHEMBL1201156
CPD000058486
CS-4913
CTK8G2012
D00816
Desmethylamitriptyline hydrochloride
DSSTox_CID_25109
DSSTox_GSID_45109
DSSTox_RID_80676
DTXSID2045109
EINECS 212-973-0
EN300-26665
EU-0100868
FT-0673146
HMS1568D10
HY-B1417
I01-17298
KS-000017PT
KS-1306
Lilly 38489
LP00868
methyl(3-{tricyclo[9.4.0.0?,?]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine hydrochloride
METHYL(3-{TRICYCLO[9.4.0.0(3),?]PENTADECA-1(15),3,5,7,11,13-HEXAEN-2-YLIDENE}PROPYL)AMINE HYDROCHLORIDE
MFCD00058024
MLS000069673
MLS001077267
MLS002222206
MLS006010656
MolPort-003-959-040
N 7048
N 7261
N-[3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl]-N-methylamine hydrochloride
N0957
NC00522
NCGC00014483-01
NCGC00094192-01
NCGC00094192-02
NCGC00261553-01
NE48409
Noramitriptyline hydrochloride
Nortab hydrochloride
Nortrilen
Nortriptylin hydrochloride
Nortriptyline (hydrochloride)
Nortriptyline for system suitability, European Pharmacopoeia (EP) Reference Standard
Nortriptyline Hcl
Nortriptyline hdrochloride
Nortriptyline hydrochloride (JP17/USP/INN)
Nortriptyline hydrochloride [USAN:USP:JAN]
Nortriptyline Hydrochloride 1.0 mg/ml in Methanol (as free base)
Nortriptyline hydrochloride, >=98% (TLC), powder
Nortriptyline hydrochloride, British Pharmacopoeia (BP) Reference Standard
Nortriptyline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Nortriptyline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Nortriptyline monohydrochloride
NORTRIPTYLINEHYDROCHLORIDE
Norzepine
NSC 169453
NSC 78248
NSC-169453
NSC-78248
NSC169453
NSC78248
Opera_ID_1915
Pamelor
Pamelor (TN)
Pamelor hydrochloride
PL049963
Prestwick_366
Psychostyl
REGID_for_CID_441358
SAM002554915
SCHEMBL41329
Sensival
SHAYBENGXDALFF-UHFFFAOYSA-N
SMR000058486
SR-01000000223
SR-01000000223-2
Tox21_110048
Tox21_500868
UNII-00FN6IH15D
Vividyl
W-109609
WLN: L C676 BY&T&J BU3M1 &GH

US Patents and Regulatory Information for NORTRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074132-004 Mar 27, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharm Assoc NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride SOLUTION;ORAL 075606-001 Aug 28, 2000 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074054-001 Dec 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 075520-003 May 8, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Boehringer Ingelheim
Chubb
McKinsey
Harvard Business School
Federal Trade Commission
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.